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INTRODUCTION 
 Sick sinus syndrome (SSS) is the most common arrhythmogenic disease that 
requires the implantation of an cardiac pacemaker (CP).  
 However, the relationship of comorbid conditions and quality of life (QoL) with 
the level of pulse blood pressure (PBP) in these patients has not yet been studied.  
THE AIM OF THE STUDY 
 To evaluate the relationship of QoL and comorbid conditions of patients with 
SSS depending on the PBP level one year after of CP implantation and 
pharmaceutical therapy  
RESEARCH VOLUME 
40 patients (25 women and 15 men) 
age 70 ± 9 years 
annual stage of maintenance drug therapy after implantation of CP 
  
  
  
INCLUSION AND EXCLUSION 
CRITERIA 
 INCLUSION CRITERIA: 
◦ implantation of cardiac pacemaker in DDD(R) mode 
 EXCLUSION CRITERIA : 
◦ age less than 40 years 
◦ the presence of concomitant angina IV functional class (FC) 
◦ chronic heart failure IV FC 
◦ stimulation of the right ventricle and / or left ventricle less than 50% over the entire observation period. 
SUPPORTING DRUG THERAPY 
Anticoagulants 
Antiplatelet agents 
Antiarrhythmic drugs 
Diuretics  
β- blockers 
Ca-channel blockers  
Angiotensin converting enzyme inhibitors  
Angiotensin II receptor blockers  
Statins 
STUDY GROUPS 
Group A 40-60 mm HG Normal PBP 
Group B > 60 mm Hg High PBP 
STATISTICAL DATA PROCESSING 
  
Microsoft Excel data base  
Non-parametric indicators: 
absolute - n, number 
relative - p,% 
Mann-Whitney U-test  
Level of confidence p <0.05 
  
CONCENTRATION OF PATIENTS 
IN THE STUDY GROUP 
Patients with implanted CP were mostly concentrated in the group with normal PBP (62.5%), less - in 
the group with high PBP (37.5%). 
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Clinical characteristics of patients with SSS 
and CP (% ± P) 
Clinical data Group A Group B 
Chronic ischemic heart 
disease  
  
  
postinfarction cardiosclerosis  33±3 60±5* 
stable angina  I FC 0 0 
II FC 24±2 X 26±2* 
III FC 12±3 40±4*X  
Arterial hypertension  1 degree 40±4 X 0 
2 degree 28±3 67±4*X 
3 degree 4±1 33±3* 
Chronic heart failure  I FC 36±4 X  20±2* 
II FC 16±2 87±6*X 
Atrial fibrillation  persistent form  28±4 X 33±4 X 
paroxysmal form 7±2 16±2* 
Примечание. *p <0,05 - между исследуемыми группами, X
p <0,05 – внутри подгрупп.
 
Note. *p <0,05 - between study groups, Xp <0,05 – within subgroups.  
INDICES OF PHYSICAL HEALTH COMPONENT 
IN PATIENTS WITH SSS AT DIFFERENT LEVELS 
OF PP ONE YEAR AFTER CP 
QoL parameters Croup A Group B 
Physical Functioning 78±6 34±4* 
Role-Physical Functioning 56±4*X 9,1±3 X 
Bodily Pain 74±5 41±4* 
General Health 66±5 28±4* 
Note. *p <0,05 - between study groups, Xp <0,05 – within subgroups.  
One year after the implantation of the CP, a decrease in the level of QoL was revealed, to a greater extent with 
high PBP. Indicators of role functioning due to physical condition were significantly reduced in both study 
groups. 
INDICES OF PSYCHOLOGICAL COMPONENT OF 
HEALTH IN PATIENTS WITH SSS AT DIFFERENT 
LEVELS OF PP ONE YEAR AFTER CP 
QoL parameters Group A Group B 
Vitality 65±5X 25±4*X 
Social Functioning 82±6 47±4* 
Role-Emotional 80±5 28±4*X 
Mental Health 77±5 38±4* 
Note. *p <0,05 - between study groups, Xp <0,05 – within subgroups.  
In the study of the psychological component of health, the impairment of patients QoL was to a greater extent 
associated with a decrease in vital activity indicators within both of the studied groups, and indicators of role 
functioning due to emotional state — within group B. 
CONCLUSION 
In patients with implanted cardiac pacemaker for sick sinus syndrome, normal PBP is most 
often found (62.5%), less common is high PBP (37.5%). 
One year after implantation, sick sinus syndrome is associated with chronic ischemic heart 
disease, arterial hypertension, chronic heart failure, and atrial fibrillation, with their incidence 
and severity increasing with the level of PBP. 
After pacemaker implantation in patients with sick sinus syndrome occurs decline in physical 
and psychological health components to a greater extent at a high level of PBP. 
After cardiac pacemaker implantation in patients with sick sinus syndrome, correction of drug 
therapy is required to normalize PBP, improve the clinical condition and increase their quality 
of life . 
